Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 7/2013

01-07-2013 | Editorials and Comment

The Coming Golden Age of Disruptive Innovation in Health Care

Authors: Eyal Zimlichman, MD, MSc, Jeffrey Levin-Scherz, MD, MBA

Published in: Journal of General Internal Medicine | Issue 7/2013

Login to get access

Excerpt

Innovation in both manufacturing and service industries often leads to increased functionality with lower prices. Cellular telephones today have more capabilities than computers that cost thousands a decade ago, and tax preparation software priced under $50 can prepare most documents as effectively as high-priced accountants. …
Literature
1.
Christensen CM, Bohmer R, Kenagy J. Will Disruptive Innovation Cure Health Care? Harv Bus Rev. 2000;78:102–12. 199.PubMed
2.
3.
Shafrin J. Operating on commission: analyzing how physician financial incentives affect surgery rates. Health Economics. 2009;19:562–80.
4.
Woolf SH, Johnson RE. The break-even point: when medical advances are less important than improving the fidelity with which they are delivered. Ann Fam Med. 2005;3:545–52.PubMedCrossRef
5.
Cutler DM, Huckman RS. Technological development and medical productivity: the diffusion of angioplasty in New York state. J Health Econ. 2003;22:187–217.PubMedCrossRef
Metadata
Title
The Coming Golden Age of Disruptive Innovation in Health Care
Authors
Eyal Zimlichman, MD, MSc
Jeffrey Levin-Scherz, MD, MBA
Publication date
01-07-2013
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 7/2013
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-013-2335-2

Other articles of this Issue 7/2013

Journal of General Internal Medicine 7/2013 Go to the issue

Capsule Commentaries

Capsule Commentary on Gawron et al., Proton Pump Inhibitor Prescriptions and Subsequent Use in US Veterans Diagnosed with Gastroesophageal Reflux Disease

Editorials

Direct-to-Consumer Television Advertising: Time to Turn Off the Tube?

Comment

The Sticking Point: Diabetic Sharps Disposal Practices in the Community

Original Research

Evaluation of VA Women’s Health Fellowships: Developing Leaders in Academic Women’s Health

Health Policy

Variation in Electronic Health Record Adoption and Readiness for Meaningful Use: 2008–2011

Letters

Community-Acquired Pneumonia and Proton Pump Inhibitors
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits